Biobanking Market Report on the Untapped Growth Opportunities in the Industry | MDC Research

Pune, April 11, 2022 (GLOBE NEWSWIRE) — The global biobanking market is driven by a high incidence of chronic diseases such as cardiovascular disease, Alzheimer’s disease, arthritis, and diabetes. Moreover, factors such as an increase in R& D funding, technological advancements in regenerative medicine, developments in drug discovery and increasing awareness about stem cell therapies. The increasing number of research activities used for predicting drug reactions is expected to support the growth of this market.

The global Biobanking Market is estimated to be valued over USD 82.17 Bn by 2030, It is anticipated to reach a CAGR over 7.8% during the forecast period from 2022 to 2030.

Biobanking Market by Region

The global biobanking market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). Currently, North America dominates the biobanking market owing to the factors such as increasing research activities, heavy investments in the field of genomics, and growing interest in biomarker discovery. Moreover, the Asia Pacific region is anticipated to propel the biobanking market during the forecast period, with a significant CAGR. Presence of a large population base in this region, especially in countries like India and China, will boost up the market. Furthermore, increasing infrastructural facilities in life sciences, as well as a rise in funds by governmental organizations in this field, is likely to drive the market in this region.

Get a Sample Copy of the Report https://www.marketdatacentre.com/sample/70

1. COMPANY PROFILES (Business Overview, Products & Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
   1. Thermo Fisher Scientific Inc.
   2. PHC Holdings Corporation
   3. QIAGEN N.V.
   4. Becton, Dickinson and Company
   5. Merck KGaA
   6. Hamilton Company
   7. Avantor, Inc.
   8. Tecan Group Ltd.
   9. BioCision
   10. Promega Corporation

 Table of contents:

1. INTRODUCTION
   1. Market Definition
   2. Market Ecosystem
      1.  Market Classification
      2.  Geographic Scope
      3.  Years Considered for the Study: Historical Years – 2017 & 2020 ; Base Year – 2021 ; Forecasted Years – 2022 to 2030
   3. Currency Used
2. RESEARCH METHODOLOGY
   1. Research Framework
   2. Data Collection Technique
   3. Data Sources
      1.  Secondary Sources
      2.  Primary Sources
   4. Market Estimation Methodology
      1.  Bottoms Up Approach
      2.  Top Down Approach
   5. Data Validation and Triangulation
      1.  Market Forecasting Model
      2.  Limitations/Assumptions of the Study
3. ABSTRACT OF THE STUDY
4. MARKET DYNAMICS ASSESMENT
   1. Overview
   2. Drivers
   3. Barriers/Challenges
   4. Opportunities
5. UNIQUE SELLING PROPOSITIONS (USPs)
   1. Technological Advancements
   2.   Research Landscape Assessment  
6. GLOBAL BIOBANKING MARKET – ANALYSIS & FORECAST, BY PRODUCT & SERVICES
   1. Equipment
      1. Sample Analysis Equipment
      2. Sample Processing Equipment
      3. Sample Transport Equipment
      4. Storage Equipment
   2. Consumables
      1. Analysis Consumables
      2. Processing Consumables
      3. Collection Consumables
      4. Storage Consumables
   3. Services
      1. Supply Services
      2. Transport Services
      3. Processing Services
      4. Storage Services
   4. Software

Vendor Assessment

Vendor assessment includes a deep analysis of how vendors are addressing  the demand in the Biobanking Market. The MDC Competetive Scape model was used to assess qualitative and quantitative insights in this assessment. MDC’s Competitive Scape is a structured method for identifying key players and outlining their strengths, relevant characteristics, and outreach strategy. MDC’s Competitive Scape allows organizations to analyze the environmental factors that influence their business, set goals, and identify new marketing strategies. MDC Research analysts conduct a thorough investigation of vendors’ solutions, services, programs, marketing, organization size, geographic focus, type of organization and strategies.

Technology Assessment

Technology dramatically impacts business productivity, growth and efficiency.Technologies can help companies develop competitive advantages, but choosing them can be one of the most demanding decisions for businesses. Technology assessment helps organizations to understand their current situation with respect to technology and offer a roadmap where they might want to go and scale their business. A well-defined process to assess and select technology solutions can help organizations reduce risk, achieve objectives, identify the problem, and solve it in the right way. Technology assessment can help businesses identify which technologies to invest in, meet industry standards, compete against competitors.

Download Sample PDF https://www.marketdatacentre.com/samplepdf/70